Home / Germany / Stada Arzneimittel Aktiengesellschaft

Stada Arzneimittel Aktiengesellschaft

No short position is open on this share today.

0.00% of the capital sold short

0 disclosing funds

140 disclosures on record

Evolution of the disclosed total

0%1%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 3.38% on March 2, 2016. The shaded band matches the twelve months of the first chart.

November 1, 2012 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Stada Arzneimittel Aktiengesellschaft by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

140 disclosures on record for this share.
Date	Fund	% of capital
July 24, 2018	Parvus Asset Management Europe Limited	0.00%
August 23, 2017	Polygon Global Partners LLP	0.00%
August 22, 2017	Polygon Global Partners LLP	0.95%
August 21, 2017	Polygon Global Partners LLP	0.82%
May 25, 2017	Sand Grove Capital Management LLP	0.23%
May 16, 2017	Sand Grove Capital Management LLP	0.00%
May 10, 2017	Sand Grove Capital Management LLP	0.47%
April 27, 2017	Sand Grove Capital Management LLP	0.33%
August 1, 2016	Marshall Wace LLP	0.46%
July 29, 2016	Marshall Wace LLP	0.50%
July 27, 2016	Marshall Wace LLP	0.49%
July 19, 2016	Marshall Wace LLP	0.59%
June 29, 2016	Marshall Wace LLP	0.69%
June 27, 2016	Marshall Wace LLP	0.77%
June 16, 2016	Marshall Wace LLP	0.88%
June 15, 2016	Marshall Wace LLP	0.90%
June 10, 2016	Marshall Wace LLP	0.82%
June 8, 2016	Marshall Wace LLP	0.73%
June 6, 2016	Marshall Wace LLP	0.68%
June 1, 2016	Marshall Wace LLP	0.70%
May 31, 2016	GAM Investment Management (switzerland) AG	0.49%
May 30, 2016	GAM Investment Management (switzerland) AG	0.55%
May 27, 2016	Marshall Wace LLP	0.69%
May 27, 2016	GAM Investment Management (switzerland) AG	0.64%
May 26, 2016	Marshall Wace LLP	0.59%
May 25, 2016	Marshall Wace LLP	0.60%
May 18, 2016	GAM Investment Management (switzerland) AG	0.77%
May 17, 2016	Marshall Wace LLP	0.77%
May 12, 2016	Marshall Wace LLP	0.89%
May 10, 2016	Marshall Wace LLP	0.91%
May 9, 2016	Marshall Wace LLP	0.89%
May 6, 2016	Marshall Wace LLP	0.90%
May 5, 2016	Marshall Wace LLP	0.88%
May 4, 2016	Marshall Wace LLP	0.90%
May 3, 2016	Marshall Wace LLP	1.12%
April 26, 2016	Marshall Wace LLP	1.47%
April 19, 2016	Marshall Wace LLP	1.59%
April 18, 2016	Parvus Asset Management Europe Limited	0.60%
March 18, 2016	Marshall Wace LLP	1.61%
March 15, 2016	Marshall Wace LLP	1.59%
March 14, 2016	Marshall Wace LLP	1.61%
March 10, 2016	Marshall Wace LLP	1.73%
March 7, 2016	Marshall Wace LLP	1.96%
March 2, 2016	Marshall Wace LLP	2.00%
March 1, 2016	Marshall Wace LLP	1.90%
February 25, 2016	Marshall Wace LLP	1.80%
February 23, 2016	Marshall Wace LLP	1.74%
February 16, 2016	Marshall Wace LLP	1.60%
February 12, 2016	Marshall Wace LLP	1.51%
February 9, 2016	Marshall Wace LLP	1.40%

Download 140 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

HelloFresh SE 7.92% of the capital sold short
AUTO1 Group SE 7.29% of the capital sold short
TUI AG 6.61% of the capital sold short
PVA TePla AG 5.87% of the capital sold short
Velo3D Inc 5.85% of the capital sold short
Hugo Boss AG 5.63% of the capital sold short
Puma SE 5.63% of the capital sold short
K+S Aktiengesellschaft 5.53% of the capital sold short
RENK Group AG 5.42% of the capital sold short
Zalando SE 5.39% of the capital sold short
Evotec SE 5.35% of the capital sold short
Ocean Power Technologies, Inc 5.27% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Stada Arzneimittel Aktiengesellschaft, source Bundesanzeiger, data as at July 24, 2018, https://www.quivad.com/action/stada-arzneimittel-aktiengesellschaft